Nucor earnings beat by $0.08, revenue fell short of estimates
Investing.com - DocuSign (NASDAQ: DOCU) reported second quarter EPS of $0.97, $0.16 better than the analyst estimate of $0.81. Revenue for the quarter came in at $736M versus the consensus estimate of $727.2M.
Guidance
DocuSign sees Q3 2025 revenue of $743.00M-$747.00M versus the analyst consensus of $739.40M.
DocuSign sees FY 2025 revenue of $2.94B-$2.95B versus the analyst consensus of $2.93B.
DocuSign's stock price closed at $56.90. It is up 9.32% in the last 3 months and up 7.81% in the last 12 months.
DocuSign saw 11 positive EPS revisions and 6 negative EPS revisions in the last 90 days. See DocuSign's stock price’s past reactions to earnings here.
According to InvestingPro, DocuSign's Financial Health score is "great performance".
Check out DocuSign's recent earnings performance, and DocuSign's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar